Addus HomeCare (NASDAQ:ADUS) Rating Increased to Strong-Buy at Wall Street Zen

Addus HomeCare (NASDAQ:ADUS) was upgraded by analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research note issued to investors on Saturday.

ADUS has been the subject of a number of other reports. BMO Capital Markets started coverage on shares of Addus HomeCare in a report on Thursday, November 13th. They issued a “market perform” rating and a $120.00 price objective for the company. Weiss Ratings reissued a “hold (c+)” rating on shares of Addus HomeCare in a research note on Wednesday, October 8th. Cowen reaffirmed a “buy” rating on shares of Addus HomeCare in a research note on Wednesday, November 5th. TD Cowen lifted their price objective on Addus HomeCare from $139.00 to $140.00 and gave the stock a “buy” rating in a report on Wednesday, November 5th. Finally, Royal Bank Of Canada increased their target price on Addus HomeCare from $134.00 to $139.00 and gave the company an “outperform” rating in a report on Friday, November 7th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Addus HomeCare presently has a consensus rating of “Moderate Buy” and a consensus price target of $136.90.

Addus HomeCare Trading Down 2.1%

Shares of ADUS stock opened at $107.50 on Friday. The business has a 50-day moving average price of $112.52 and a two-hundred day moving average price of $113.25. Addus HomeCare has a 12-month low of $88.96 and a 12-month high of $136.72. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.14. The firm has a market cap of $1.99 billion, a P/E ratio of 23.02, a price-to-earnings-growth ratio of 1.32 and a beta of 0.92.

Addus HomeCare (NASDAQ:ADUS) last released its earnings results on Monday, November 3rd. The company reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.53 by $0.03. The company had revenue of $362.30 million during the quarter, compared to the consensus estimate of $354.48 million. Addus HomeCare had a return on equity of 9.53% and a net margin of 6.36%.Addus HomeCare’s quarterly revenue was up 25.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.30 EPS. Equities analysts anticipate that Addus HomeCare will post 4.59 EPS for the current fiscal year.

Insider Buying and Selling

In related news, EVP Darby Anderson sold 20,000 shares of the stock in a transaction dated Wednesday, November 19th. The shares were sold at an average price of $109.00, for a total value of $2,180,000.00. Following the completion of the transaction, the executive vice president directly owned 44,144 shares of the company’s stock, valued at $4,811,696. This represents a 31.18% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In the last three months, insiders have sold 20,316 shares of company stock valued at $2,215,998. 4.50% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in ADUS. Larson Financial Group LLC lifted its stake in shares of Addus HomeCare by 133.3% in the 3rd quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock valued at $28,000 after purchasing an additional 136 shares during the period. AlphaQuest LLC purchased a new position in Addus HomeCare during the third quarter valued at $37,000. Wexford Capital LP bought a new stake in shares of Addus HomeCare during the 3rd quarter valued at $41,000. State of Wyoming bought a new stake in shares of Addus HomeCare during the 2nd quarter valued at $47,000. Finally, Raymond James Financial Inc. bought a new position in shares of Addus HomeCare in the 2nd quarter worth about $61,000. Hedge funds and other institutional investors own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.